Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 24463664)

1.

High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer.

Thomsen LT, Frederiksen K, Munk C, Junge J, Castle PE, Iftner T, Kjaer SK.

Obstet Gynecol. 2014 Jan;123(1):57-64. doi: 10.1097/AOG.0000000000000056.

PMID:
24463664
2.

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

Kjær SK, Frederiksen K, Munk C, Iftner T.

J Natl Cancer Inst. 2010 Oct 6;102(19):1478-88. doi: 10.1093/jnci/djq356. Epub 2010 Sep 14.

3.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

4.

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

Carozzi F, Gillio-Tos A, Confortini M, Del Mistro A, Sani C, De Marco L, Girlando S, Rosso S, Naldoni C, Dalla Palma P, Zorzi M, Giorgi-Rossi P, Segnan N, Cuzick J, Ronco G; NTCC working group.

Lancet Oncol. 2013 Feb;14(2):168-76. doi: 10.1016/S1470-2045(12)70529-6. Epub 2012 Dec 21.

PMID:
23261355
5.

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD.

J Natl Cancer Inst. 2010 Mar 3;102(5):315-24. doi: 10.1093/jnci/djq001. Epub 2010 Feb 15.

6.

Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.

Pretorius RG, Peterson P, Azizi F, Burchette RJ.

Am J Obstet Gynecol. 2006 Nov;195(5):1260-5.

PMID:
17074547
7.

[Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].

Liu M, Wang CX, Deng XM, Wang LS, Zhang J, Li W, Zheng GX, Wang JF.

Zhonghua Liu Xing Bing Xue Za Zhi. 2007 May;28(5):487-90. Chinese.

PMID:
17877181
8.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

PMID:
16978225
9.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
10.

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R.

Rev Panam Salud Publica. 2004 Feb;15(2):75-89.

PMID:
15030652
11.

High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.

Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP.

J Low Genit Tract Dis. 2013 Jan;17(1):51-7. doi: 10.1097/LGT.0b013e31824ddbe0.

PMID:
22885641
12.

[Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].

Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jul;43(7):565-70. Chinese.

PMID:
19954065
13.

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.

J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.

14.

Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.

Jensen KE, Schmiedel S, Frederiksen K, Norrild B, Iftner T, Kjær SK.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1949-55. doi: 10.1158/1055-9965.EPI-12-0663. Epub 2012 Sep 26.

15.

Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC).

Zeferino LC, Rabelo-Santos SH, Villa LL, Sarian LO, Costa MC, do Amaral Westin MC, de Ângelo-Andrade LA, Derchain S.

Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):160-4. doi: 10.1016/j.ejogrb.2011.05.023. Epub 2011 Jun 15.

16.

Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.

Kim CJ, Lee YS, Kwack HS, Yoon WS, Park TC, Park JS.

Int J Gynecol Cancer. 2010 Aug;20(6):1067-73. doi: 10.1111/IGC.0b013e3181e4a720.

PMID:
20683419
17.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

18.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
19.

HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.

Zielinski GD, Rozendaal L, Voorhorst FJ, Berkhof J, Snijders PJ, Risse EJ, Runsink AP, de Schipper FA, Meijer CJ.

Gynecol Oncol. 2003 Oct;91(1):67-73.

PMID:
14529664
20.

Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.

Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL.

Int J Cancer. 2010 Sep 1;127(5):1151-7. doi: 10.1002/ijc.25144.

PMID:
20039323
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk